SOURCE: Myriad Genetics

March 06, 2008 06:45 ET

Myriad Genetics to Present at the Lehman Brothers Healthcare Conference on March 19, 2008

SALT LAKE CITY, UT--(Marketwire - March 6, 2008) - Myriad Genetics, Inc. (NASDAQ: MYGN), announced today that Peter Meldrum, President and CEO, is scheduled to present an overview of the Company at the 11th Annual Lehman Brothers Global Healthcare Conference, at 9:30 a.m. on March 19, at the Loews Miami Beach Hotel in South Beach, Florida.

A live audio webcast of this presentation will be available online and can be accessed through a link on Myriad's home page at www.myriad.com.

Myriad Genetics, Inc. is a biopharmaceutical company focused on the development of novel healthcare products. The Company develops and markets predictive medicine products, and is developing and intends to market therapeutic products. Myriad's news and other information are available on the Company's Web site at www.myriad.com.

Contact Information